Health Canada approves first RSV vaccine for seniors
Health Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over, manufacturer GSK says.
Health Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over, manufacturer GSK says.